Keyphrases
Parkinson's Disease
100%
Autophagy
100%
Mammalian Target of Rapamycin Signaling
100%
Mammalian Target of Rapamycin (mTOR)
60%
Recent Advances
20%
Dysregulation
20%
Neurodegenerative Diseases
20%
Substantia Nigra Pars Compacta
20%
Disease Treatment
20%
Cell Proliferation
20%
Complex Proteins
20%
Lysosome
20%
Dopaminergic Neuron Loss
20%
Lewy Bodies
20%
Disease Pathogenesis
20%
Drug Development
20%
Autophagy Pathway
20%
Cell Growth
20%
Reformation
20%
Initiation Mechanism
20%
Clinical Translation
20%
Mammalian Target of Rapamycin Signaling Pathway
20%
Vps34
20%
Mammalian Target of Rapamycin Pathway
20%
Transcription Factor E3 (TFE3)
20%
Multiple Aspects
20%
Central Regulator
20%
Cell Life
20%
Intracellular Distribution
20%
Medicine and Dentistry
Treatment of Parkinson's Disease
100%
Autophagy
100%
Mechanistic Target of Rapamycin
100%
Parkinson's Disease
57%
Cell Signaling Pathway
14%
Lysosome
14%
Phosphotransferase
14%
Lifespan
14%
Cell Growth
14%
Degenerative Disease
14%
Dopaminergic Neuron
14%
Substantia Nigra Pars Compacta
14%
Lewy Body
14%
Protein Targeting
14%
Neuroscience
Treatment of Parkinson's Disease
100%
Autophagy
100%
Mammalian Target of Rapamycin
100%
Parkinson's Disease
57%
Substantia Nigra Pars Compacta
14%
Neurodegenerative Disorder
14%
Lysosome
14%
Lewy Body
14%
Dopaminergic Neuron
14%
Cell Signaling
14%
Kinase
14%
Cell Growth
14%
Protein Targeting
14%
Biochemistry, Genetics and Molecular Biology
Autophagy
100%
Mechanistic Target of Rapamycin
100%
Subcellular Localization
14%
Kinase
14%
Phosphotransferase
14%
Dopaminergic
14%
Lifespan
14%
Cell Growth
14%
Lysosome
14%
TFEB
14%
TFE3
14%
Vacuolar Protein Sorting
14%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
100%
Mammalian Target of Rapamycin
100%
Degenerative Disease
14%
Phosphotransferase
14%
Dopamine Receptor Stimulating Agent
14%
Lewy Body
14%
Drug Development
14%